Reunion Capital Partners provides independent capital market advisory services to companies and their owners, board and management teams in relation to all facets and interactions with the equity capital markets. We have an unparalleled level of knowledge and experience of equity capital markets amongst the independent advisory community in Australia, with over 75 years of combined securities industry experience across equity capital markets, institutional equity sales and research.
Mike has over 30 years securities industry experience covering institutional equity sales, equities research and equity capital markets.
Michael entered the securities industry in 1985 with Eyres Reed McIntosh in Perth, before moving into equities research, and transferring as an analyst to McIntosh Hamson Hoare Govett in Melbourne in 1988.
He jointed Hartley Poynton in Perth in 1990, where he established an equities research department, becoming a partner in 1992.
In 1995, Michael joined County Natwest Australia (later renamed Citibank) where he performed a number of roles including equities research analyst in Sydney, Australian research sales in New York and moved into the Equity Capital Markets team in 1999 in Sydney.
Michael joined Goldman Sachs in June 2002 to establish Goldman Sachs’ capital markets business in Australia.
After the merger with JBWere, Michael became Co-Head of Equity Capital Markets of Goldman Sachs JBWere and subsequently Co-Head of the Financing Group until 2013.
Michael founded Reunion Capital Partners in October, 2013.
Rob has over 25 years securities industry experience, working with Goldman Sachs Australia and its predecessor firms (JBWere, Goldman Sachs JBWere and Goldman Sachs & Partners Australia) from 1991 to 2013 where, prior to joining Reunion Capital Partners, Rob was a Managing Director in equity capital markets.
Rob joined JBWere in 1991 as part of the Capital Markets team where he was responsible for sales and trading of fixed income and hybrid securities.
In 1995, Rob joined JBWere’s equity finance team where he was responsible for management of the structured lending portfolio.
From 1998 to 2013, Rob was a key member of Goldman Sachs Australia’s equity capital markets team. He focused on the origination, structuring and execution equity and hybrid transactions and capital management advice.
Gordon has over 20 years’ experience as an equity analyst and in institutional research sales including 14 years with Goldman Sachs and its predecessor firm in Australia, JBWere. Gordon has serviced clients in Australia, the US and UK/Europe.
Prior to joining Reunion Capital, Gordon established Dissero in 2017 to provide companies with a full range of investor relations services and equity market support.
We use our transactional knowledge, experience and deep understanding of the investment community to optimise our client’s outcomes for the full range equity capital markets related activities including:
Initial Public Offers
Pre-IPO structuring and preparation including feasibility analysis, development of the investment thesis, capital structure, board appointments and financial disclosure. IPO execution including overall IPO project management, prospectus preparation, appointment of underwriters and other service providers and review of and advice on underwriter marketing activities, share allocation and pricing recommendations.
Follow On Capital Raising & Share Sales
Preparation and structuring of follow on equity capital raisings and secondary share sales including development of offer/sale strategy, offer structure preparation, underwriter selection and appointment process
Strategic Advice to Boards & Senior Management
Independent review of and advice on strategic proposals, transactions and initiatives including strategic Investor Relations, advice on and assistance with investor targeting and investor engagement strategies and investor reaction analysis in the context of “normal course” investor relations or potential M&A activity. Capital Management including evaluation, structuring and execution of capital management initiatives including share buybacks and dividend policy.
Our Recent Roles
|September 2021||A$505 million||Independent Advisor to Jacobs Engineering Group in connection with block trade|
|June 2021||A$40 million||Independent Financial Advisorin relation to InstitutionalPlacement & Share PurchasePlan|
|May 2021||A$500 million||Independent Financial Advisor in connection with IPO|
|November 2020||A$750 million||Independent Financial Advisorin relation to InstitutionalPlacement & Share PurchasePlan|
|July 2020||A$15 million||Independent Financial Advisor in connection with placement and entitlement offer|
|April 2020||c.A$1.5 billion||Independent Financial Advisorin relation to InstitutionalPlacement & Share PurchasePlan|
|December 2019||A$48 million||Independent Financial Advisor in connection with IPO|
|February 2019||A$300 million||Independent Advisor to Tilt Renewablesl in connection with entitlement offer|
|February 2017||A$355 million||Independent Advisor to Bain Capital in connection with block trade|
|August 2016||A$350 million||Independent Advisor to Carlyle Group in connection with block trade|
|June 2016||A$294 million||Independent Financial Advisor in connection with IPO|
|June 2016||A$950 million||Independent Advisor to StatePlus in connection with dual-tracksale process|
|May 2016||A$188 million||Independent Advisor to GTCR in connection with GTN IPO|
|June 2015||A$500 million||Independent Advisor to IAG in connection with Strategic Relationship with and Placement to Berkshire Hathaway|
|June 2015||A$207 million||Independent Financial Advisorto IPO|
|May 2015||A$833 million||Independent Financial Advisorto IPO|
|March 2015||A$250 million||Independent Financial Advisorto IPO|
|November 2014||A$5.7 billion||Independent Financial Advisorto IPO|
|June 2014||A$640 million||Independent Financial Advisorto IPO|
|May 2014||A$140 million||Independent Financial Advisorto IPO|
|March 2014||c.A$1.0 billion||Independent Advisor toBoard & Management ofWesfarmers Insurance Broking|
|December 2013||c.A$1.43 billion||Independent Financial Advisorin relation to InstitutionalPlacement & Share PurchasePlan|